Afatinib in EGFR TKI-Naïve Patients with Locally Advanced or Metastatic EGFR Mutation-Positive Non-Small Cell Lung Cancer: A Pooled Analysis of Three Phase IIIb Studies von Passaro, Antonio, de Marinis, Filippo, Tu, Hai-Yan, Laktionov, Konstantin K., Feng, Jifeng, Poltoratskiy, Artem, Zhao, Jun, Tan, Eng Huat, Gottfried, Maya, Lee, Victor, Kowalski, Dariusz, Yang, Cheng Ta, Srinivasa, BJ, Clementi, Laura, Jalikop, Tejaswini, Huang, Dennis Chin Lun, Cseh, Agnieszka, Park, Keunchil, Wu, Yi-Long

Volltext

Selumetinib Plus Docetaxel Compared With Docetaxel Alone and Progression-Free Survival in Patients With KRAS-Mutant Advanced Non–Small Cell Lung Cancer: The SELECT-1 Randomized Cli... von Jänne, Pasi A, van den Heuvel, Michel M, Barlesi, Fabrice, Cobo, Manuel, Mazieres, Julien, Crinò, Lucio, Orlov, Sergey, Blackhall, Fiona, Wolf, Juergen, Garrido, Pilar, Poltoratskiy, Artem, Mariani, Gabriella, Ghiorghiu, Dana, Kilgour, Elaine, Smith, Paul, Kohlmann, Alexander, Carlile, David J, Lawrence, David, Bowen, Karin, Vansteenkiste, Johan

Volltext

Patient-reported outcomes with first-line durvalumab plus platinum-etoposide versus platinum-etoposide in extensive-stage small-cell lung cancer (CASPIAN): a randomized, controlled... von Goldman, Jonathan W., Garassino, Marina Chiara, Chen, Yuanbin, Özgüroğlu, Mustafa, Dvorkin, Mikhail, Trukhin, Dmytro, Statsenko, Galina, Hotta, Katsuyuki, Ji, Jun Ho, Hochmair, Maximilian J., Voitko, Oleksandr, Havel, Libor, Poltoratskiy, Artem, Losonczy, György, Reinmuth, Niels, Patel, Nikunj, Laud, Peter J., Shire, Norah, Jiang, Haiyi, Paz-Ares, Luis

Volltext

Afatinib in EGFR TKI-naïve patients with locally advanced or metastatic EGFR mutation-positive non-small cell lung cancer: Interim analysis of a Phase 3b study von de Marinis, Filippo, Laktionov, Konstantin K., Poltoratskiy, Artem, Egorova, Inna, Hochmair, Maximilian, Passaro, Antonio, Migliorino, Maria Rita, Metro, Giulio, Gottfried, Maya, Tsoi, Daphne, Ostoros, Gyula, Rizzato, Simona, Mukhametshina, Guzel Z., Schumacher, Michael, Novello, Silvia, Dziadziuszko, Rafal, Tang, Wenbo, Clementi, Laura, Cseh, Agnieszka, Kowalski, Dariusz

Volltext

O11-5 Durvalumab(D) ± tremelimumab(T) + platinum-etoposide(EP) in 1L ES-SCLC: Characterization of long-term benefit in CASPIAN von Saito, Haruhiro, Goldman, Jonathan W., Garassino, Marina Chiara, Chen, Yuanbin, Reinmuth, Niels, Hotta, Katsuyuki, Poltoratskiy, Artem, Trukhin, Dmytro, Hochmair, Maximilian J., Özgüroğlu, Mustafa, Ji, Jun Ho, Statsenko, Galina, Voitko, Oleksandr, Conev, Nikolay V., Bondarenko, Igor, Spencer, Stuart, Xie, Mingchao, Jones, Stephanie, Franks, April, Shrestha, Yashaswi, Paz-Ares, Luis

Volltext

Randomized phase II study of pemetrexed/cisplatin with or without axitinib for non-squamous non-small-cell lung cancer von Belani, Chandra P, Yamamoto, Nobuyuki, Bondarenko, Igor M, Poltoratskiy, Artem, Novello, Silvia, Tang, Jie, Bycott, Paul, Niethammer, Andreas G, Ingrosso, Antonella, Kim, Sinil, Scagliotti, Giorgio V

Volltext

Durvalumab ± tremelimumab + platinum-etoposide in first-line extensive-stage SCLC (ES-SCLC): Updated results from the phase III CASPIAN study von Paz-Ares, Luis G., Dvorkin, Mikhail, Chen, Yuanbin, Reinmuth, Niels, Hotta, Katsuyuki, Trukhin, Dmytro, Statsenko, Galina, Hochmair, Maximilian, Özgüroğlu, Mustafa, Ji, Jun Ho, Voitko, Oleksandr, Poltoratskiy, Artem, Verderame, Francesco, Havel, Libor, Bondarenko, Igor, Armstrong, Jon, Byrne, Natalie, Jiang, Haiyi, Goldman, Jonathan Wade

Volltext

Selumetinib Plus Docetaxel Compared With Docetaxel Alone and Progression-Free Survival in Patients With KRAS-Mutant Advanced Non-Small Cell Lung Cancer: The SELECT-1 Randomized Cli... von Jänne, Pasi A, van den Heuvel, Michel M, Barlesi, Fabrice, Cobo, Manuel, Mazieres, Julien, Crinò, Lucio, Orlov, Sergey, Blackhall, Fiona, Wolf, Juergen, Garrido, Pilar, Poltoratskiy, Artem, Mariani, Gabriella, Ghiorghiu, Dana, Kilgour, Elaine, Smith, Paul, Kohlmann, Alexander, Carlile, David J, Lawrence, David, Bowen, Karin, Vansteenkiste, Johan

Volltext

784 Immune profiling of patients with advanced melanoma intratumorally treated with CV8102 as a single-agent or in combination with anti-PD-1 antibodies – results of a phase I tria... von Gonzalez, Marina, Wengenmayer, Peter, Samoylenko, Igor, Ochsenreither, Sebastian, Richtig, Erika, Thomas, Ioannis, Erdmann, Michael, Lebbe, Celeste, Martin-Liberal, Juan, Terheyden, Patrick, Poltoratskiy, Artem, Sekacheva, Marina, Semiletova, Yuliya, Eigentler, Thomas, Schmitt-Bormann, Beate, Vahrenhorst, Dominik, Sarah-Katharina Kays, Seibel, Tobias, Quintini, Gianluca, Scheel, Birgit, Falk, Martin, Gnad-Vogt, Ulrike, Codó, Paula

Volltext

P2.03b-031 Impact of PD-L1 Status on Clinical Response in SELECT-1: Selumetinib + Docetaxel in KRASm Advanced NSCLC von Jänne, Pasi, Van Den Heuvel, Michel, Barlesi, Fabrice, Cobo, Manuel, Mazieres, Julien, Crinò, Lucio, Orlov, Sergey, Blackhall, Fiona, Wolf, Jürgen, Garrido, Pilar, Mariani, Gabriella, Poltoratskiy, Artem, Ghiorghiu, Dana, Mckeown, Astrid, Kilgour, Elaine, Angell, Helen, Smith, Paul, Kohlmann, Alexander, Lawrence, David, Bowen, Karin, Vansteenkiste, Johan

Volltext

P2.03b-031 Impact of PD-L1 Status on Clinical Response in SELECT-1: Selumetinib + Docetaxel in KRASm Advanced NSCLC: Topic: Biomarkers von Jänne, Pasi, Van Den Heuvel, Michel, Barlesi, Fabrice, Cobo, Manuel, Mazieres, Julien, Crinò, Lucio, Orlov, Sergey, Blackhall, Fiona, Wolf, Jürgen, Garrido, Pilar, Mariani, Gabriella, Poltoratskiy, Artem, Ghiorghiu, Dana, Mckeown, Astrid, Kilgour, Elaine, Angell, Helen, Smith, Paul, Kohlmann, Alexander, Lawrence, David, Bowen, Karin, Vansteenkiste, Johan

Volltext

BA2-4. Durvalumab + Platinum-Etoposide vs Platinum-Etoposide in 1L Extensive-Stage SCLC : CASPIAN Study von Koichi Azuma, Luis Paz-Ares, Yuanbin Chen, Niels Reinmuth, Katsuyuki Hotta, Dmytro Trukhin, Galina Statsenko, Maximilian J. Hochmair, Mustafa Ozguroglu, Jun Ho Ji, Oleksandr Voitko, Artem Poltoratskiy, Santiago Ponce, Francesco Verderame, Libor Havel, Igor Bondarenko, Andrzej Kazarnowicz, Gyorgy Losonczy, Nikolay V. Conev, Jon Armstrong, Natalie Byrne, Norah Shire, Haiyi Jiang, Jonathan W Goldman

Volltext